Clinical, epidemiological, and laboratory prognostic factors in patients with leprosy reactions: A 10-year retrospective cohort study

Leprosy reactions, the main cause of neural damage, can occur up to 7 years after starting multidrug therapy. We aimed to approach the prognostic factors that may influence the leprosy reactions over the follow-up time. Retrospective cohort study, encompassing 10 years of data collection, composed o...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in medicine Vol. 9; p. 841030
Main Authors: Antunes, Douglas Eulálio, Santos, Diogo Fernandes, Lima, Mayara Ingrid Sousa, Caixeta, Larissa Pereira, Correa, Meydson Benjamin Carvalho, Moraes, Emilly Caroline Dos Santos, Conceição, Natalia Carine Almeida, Goulart, Luiz Ricardo, Goulart, Isabela Maria Bernardes
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 25-07-2022
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Leprosy reactions, the main cause of neural damage, can occur up to 7 years after starting multidrug therapy. We aimed to approach the prognostic factors that may influence the leprosy reactions over the follow-up time. Retrospective cohort study, encompassing 10 years of data collection, composed of 390 patients, divided into 201 affected by reactions and 189 reaction-free individuals. Epidemiological, clinical, and laboratory variables were approached as prognostic factors associated with leprosy reactions. The association among variables was analyzed by a binomial test and survival curves were compared by the Kaplan-Meier and Cox proportional-hazards regression. 51.5% (201/390) of patients were affected by leprosy reactions. These immunological events were associated with lepromatous leprosy (16.2%; 63/390; < 0.0001) and multibacillary group (43%; 169/390; < 0.0001). This study showed that survival curves for the prognostic factor anti-PGL-I, comparing positive and negative cases at diagnosis, differed in relation to the follow-up time (Log Rank: = 0.0760; Breslow: = 0.0090; Tarone-Ware: = 0.0110). The median survival times (time at which 50% of patients were affected by leprosy reactions) were 5 and 9 months for those reactional cases with negative (26/51) and positive serology (75/150), respectively. The time-dependent covariates in the cox proportional-hazards regression showed anti-PGL-I as the main prognostic factor to predict leprosy reactions (hazard ratio=1.91; = 0.0110) throughout the follow-up time. Finally, these findings demonstrated that anti-PGL-I serology at diagnosis is the most important prognostic factor for leprosy reactions after starting multidrug therapy, thus enabling prediction of this immunological event.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Cleverson Teixeira Soares, Instituto Lauro de Souza Lima, Brazil
Reviewed by: Tarun Narang, Postgraduate Institute of Medical Education and Research, India; Vânia Nieto Brito De Souza, Instituto Lauro de Souza Lima, Brazil; Shankargouda Patil, Jazan University, Saudi Arabia
These authors have contributed equally to this work
This article was submitted to Infectious Diseases-Surveillance, Prevention and Treatment„ a section of the journal Frontiers in Medicine
ISSN:2296-858X
2296-858X
DOI:10.3389/fmed.2022.841030